{ "labelLang" : "hun", "responseDate" : "2024-03-28 12:02", "content" : { "otype" : "BookChapter", "mtid" : 25269519, "status" : "APPROVED", "published" : true, "comment" : "Cited By :28 \n Export Date: 22 June 2023", "unhandledTickets" : 0, "oldTimestamp" : "2017-06-19T08:11:15.000+0000", "deleted" : false, "oldId" : 15269519, "lastRefresh" : "2023-12-06T17:42:41.952+0000", "lastModified" : "2017-06-19T08:11:15.000+0000", "created" : "2016-01-12T13:26:11.000+0000", "creator" : { "otype" : "Author", "mtid" : 10002737, "link" : "/api/author/10002737", "label" : "Kárpáti Sarolta (Bõrgyógyászat, genetika)", "familyName" : "Kárpáti", "givenName" : "Sarolta", "published" : true, "oldId" : 10002737, "snippet" : true }, "lastDuplumOK" : "2023-06-22T13:13:35.829+0000", "lastDuplumSearch" : "2023-06-22T13:13:35.829+0000", "core" : false, "citation" : true, "publicationPending" : false, "type" : { "otype" : "PublicationType", "mtid" : 25, "link" : "/api/publicationtype/25", "label" : "Könyvrészlet", "code" : 25, "otypeName" : "BookChapter", "listPosition" : 2, "published" : true, "oldId" : 25, "snippet" : true }, "subType" : { "otype" : "SubType", "mtid" : 10000398, "link" : "/api/subtype/10000398", "label" : "Könyvfejezet (Könyvrészlet)", "name" : "Könyvfejezet", "nameEng" : "Chapter", "docType" : { "otype" : "PublicationType", "mtid" : 25, "link" : "/api/publicationtype/25", "label" : "Könyvrészlet", "code" : 25, "otypeName" : "BookChapter", "listPosition" : 2, "published" : true, "oldId" : 25, "snippet" : true }, "listPosition" : 220, "published" : true, "oldId" : 10000398, "snippet" : true }, "category" : { "otype" : "Category", "mtid" : 1, "link" : "/api/category/1", "label" : "Tudományos", "published" : true, "oldId" : 1, "snippet" : true }, "languages" : [ { "otype" : "Language", "mtid" : 10002, "link" : "/api/language/10002", "label" : "Angol", "name" : "Angol", "nameEng" : "English", "published" : true, "oldId" : 2, "snippet" : true } ], "firstAuthor" : "Wojnarowska, F", "authorships" : [ { "otype" : "PersonAuthorship", "mtid" : 43466788, "link" : "/api/authorship/43466788", "label" : "Wojnarowska, F", "listPosition" : 1, "share" : 0.0, "first" : true, "last" : false, "familyName" : "Wojnarowska", "givenName" : "F", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "oldId" : 76248916, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 43466789, "link" : "/api/authorship/43466789", "label" : "Venning, VA", "listPosition" : 2, "share" : 0.0, "first" : false, "last" : true, "familyName" : "Venning", "givenName" : "VA", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "oldId" : 76248915, "snippet" : true } ], "title" : "Immunobullous Diseases", "identifiers" : [ { "otype" : "PublicationIdentifier", "mtid" : 10117733, "link" : "/api/publicationidentifier/10117733", "label" : "DOI: 10.1002/9781444317633.ch40", "source" : { "otype" : "PlainSource", "mtid" : 6, "link" : "/api/publicationsource/6", "label" : "DOI", "type" : { "otype" : "PublicationSourceType", "mtid" : 10001, "link" : "/api/publicationsourcetype/10001", "label" : "DOI", "mayHaveOa" : true, "published" : true, "snippet" : true }, "name" : "DOI", "nameEng" : "DOI", "linkPattern" : "https://doi.org/@@@", "publiclyVisible" : true, "published" : true, "oldId" : 6, "snippet" : true }, "validState" : "IDENTICAL", "idValue" : "10.1002/9781444317633.ch40", "realUrl" : "https://doi.org/10.1002/9781444317633.ch40", "published" : false, "oldId" : 10841974, "snippet" : true }, { "otype" : "PublicationIdentifier", "mtid" : 10117732, "link" : "/api/publicationidentifier/10117732", "label" : "Scopus: 84888716120", "source" : { "otype" : "PlainSource", "mtid" : 3, "link" : "/api/publicationsource/3", "label" : "Scopus", "type" : { "otype" : "PublicationSourceType", "mtid" : 10003, "link" : "/api/publicationsourcetype/10003", "label" : "Indexelő adatbázis", "mayHaveOa" : false, "published" : true, "snippet" : true }, "name" : "Scopus", "linkPattern" : "http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@", "publiclyVisible" : true, "published" : true, "oldId" : 3, "snippet" : true }, "validState" : "IDENTICAL", "idValue" : "84888716120", "realUrl" : "http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-84888716120", "published" : false, "oldId" : 10841973, "snippet" : true } ], "firstPage" : "1855", "lastPage" : "1916", "firstPageOrInternalIdForSort" : "1855", "pageLength" : 62, "publishedYear" : 2010, "digital" : null, "printed" : null, "sourceYear" : 2016, "packet" : "566660", "foreignEdition" : true, "foreignLanguage" : true, "fullPublication" : true, "conferencePublication" : false, "nationalOrigin" : null, "missingAuthor" : false, "oaType" : "NONE", "oaCheckDate" : "2023-12-06", "oaFree" : false, "citationCount" : 0, "citationCountUnpublished" : 0, "citationCountWoOther" : 0, "independentCitCountWoOther" : 0, "doiCitationCount" : 0, "wosCitationCount" : 0, "scopusCitationCount" : 0, "independentCitationCount" : 0, "unhandledCitationCount" : 0, "citingPubCount" : 0, "independentCitingPubCount" : 0, "unhandledCitingPubCount" : 0, "citedPubCount" : 11, "citedCount" : 11, "referenceList" : "Kirtschig, G., Wojnarowska, F., Autoimmune blistering diseases: an update of diagnostic methods and investigations (1994) Clin Exp Dermatol, 19, pp. 97-112; \n\nKemler, R., From cadherins to catenins: cytoplasmic protein interactions and regulation of cell adhesion (1993) Trends Genet, 9, pp. 317-321; \n\nBuxton, R.S., Magee, A.I., Structure and interactions of desmosomal and other cadherins (1992) Semin Cell Biol, 3, pp. 157-167; \n\nGarrod, D., Chidgey, M., Desmosome structure, composition and function (2008) Biochim Biophys Acta, 1778, pp. 572-587; \n\nHanakawa, Y., Schechter, N.M., Lin, C., Molecular mechanisms of blister formation in bullous impetigo and staphylococcal scalded skin syndrome (2002) J Clin Invest, 110, pp. 53-60; \n\nAmagai, M., Koch, P.J., Nishikawa, T., Pemphigus vulgaris antigen (desmoglein 3) is localized in the lower epidermis, the site of blister formation in patients (1996) J Invest Dermatol, 106, pp. 351-355; \n\nHashimoto, T., Amagai, M., Garrod, D.R., Immunofluorescence and immunoblot studies on the reactivity of pemphigus vulgaris and pemphigus foliaceus sera with desmoglein 3 and desmoglein 1 (1995) Epithelial Cell Biol, 4, pp. 63-69; \n\nMahoney, M.G., Wang, Z., Rothenberger, K., Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris (1999) J Clin Invest, 103, pp. 461-468; \n\nShirakata, Y., Amagai, M., Hanakawa, Y., Lack of mucosal involvement in pemphigus foliaceus may be due to low expression of desmoglein 1 (1998) J Invest Dermatol, 110, pp. 76-78; \n\nHarman, K.E., Gratian, M.J., Bhogal, B.S., The use of two substrates to improve the sensitivity of indirect immunofluorescence in the diagnosis of pemphigus (2000) Br J Dermatol, 142, pp. 1135-1139; \n\nWu, H., Wang, Z.H., Yan, A., Protection against pemphigus foliaceus by desmoglein 3 in neonates (2000) N Engl J Med, 343, pp. 31-35; \n\nCampo-Voegeli, A., Muniz, F., Mascaro, J.M., Neonatal pemphigus vulgaris with extensive mucocutaneous lesions from a mother with oral pemphigus vulgaris (2002) Br J Dermatol, 147, pp. 801-805; \n\nPeifer, M., McCrea, P.D., Green, K.J., The vertebrate adhesive junction proteins beta-catenin and plakoglobin and the Drosophila segment polarity gene armadillo form a multigene family with similar properties (1992) J Cell Biol, 118, pp. 681-691; \n\nRoh, J.Y., Stanley, J.R., Plakoglobin binding by human Dsg3 (pemphigus vulgaris antigen) in keratinocytes requires the cadherin-like intracytoplasmic segment (1995) J Invest Dermatol, 104, pp. 720-724; \n\nDiColandrea, T., Karashima, T., Maatta, A., Subcellular distribution of envoplakin and periplakin: insights into their role as precursors of the epidermal cornified envelope (2000) J Cell Biol, 151, pp. 573-586; \n\nMahoney, M.G., Aho, S., Uitto, J., The members of the plakin family of proteins recognized by paraneoplastic pemphigus antibodies include periplakin (1998) J Invest Dermatol, 111, pp. 308-313; \n\nMcMillan, J.R., Shimizu, H., Desmosomes: structure and function in normal and diseased epidermis (2001) J Dermatol, 28, pp. 291-298; \n\nNorth, A.J., Bardsley, W.G., Hyam, J., Molecular map of the desmosomal plaque (1999) J Cell Sci, 112, pp. 4325-4336; \n\nKorman, N.J., Pemphigus (1990) Dermatol Clin, 8, pp. 689-700; \n\nWilson, C., Wojnarowska, F., Mehra, N.K., Pemphigus in Oxford, UK, and New Delhi, India: a comparative study of disease characteristics and HLA antigens (1994) Dermatology, 189 (SUPPL. 1), pp. 108-110; \n\nAdam, B.A., Bullous diseases in Malaysia: epidemiology and natural history (1992) Int J Dermatol, 31, pp. 42-45; \n\nChams-Davatchi, C., Valikhani, M., Daneshpazhooh, M., Pemphigus: analysis of 1209 cases (2005) Int J Dermatol, 44, pp. 470-476; \n\nAboobaker, J., Morar, N., Ramdial, P.K., Pemphigus in South Africa (2001) Int J Dermatol, 40, pp. 115-119; \n\nFirooz, A., Mazhar, A., Ahmed, A.R., Prevalence of autoimmune diseases in the family members of patients with pemphigus vulgaris (1994) J Am Acad Dermatol, 31, pp. 434-437; \n\nStarzycki, Z., Chorzelski, T.P., Jablonska, S., Familial pemphigus vulgaris in mother and daughter (1998) Int J Dermatol, 37, pp. 211-214; \n\nBrandsen, R., Frusic-Zlotkin, M., Lyubimov, H., Circulating pemphigus IgG in families of patients with pemphigus: comparison of indirect immunofluorescence, direct immunofluorescence, and immunoblotting (1997) J Am Acad Dermatol, 36, pp. 44-52; \n\nAhmed, A.R., Yunis, E.J., Khatri, K., Major histocompatibility complex haplotype studies in Ashkenazi Jewish patients with pemphigus vulgaris (1990) Proc Natl Acad Sci USA, 87, pp. 7658-7662; \n\nAhmed, A.R., Wagner, R., Khatri, K., Major histocompatibility complex haplotypes and class II genes in non-Jewish patients with pemphigus vulgaris (1991) Proc Natl Acad Sci USA, 88, pp. 5056-5060; \n\nAhmed, A.R., Mohimen, A., Yunis, E.J., Linkage of pemphigus vulgaris antibody to the major histocompatibility complex in healthy relatives of patients (1993) J Exp Med, 177, pp. 419-424; \n\nMiyagawa, S., Amagai, M., Niizeki, H., HLA-DRB1 polymorphisms and autoimmune responses to desmogleins in Japanese patients with pemphigus (1999) Tissue Antigens, 54, pp. 333-340; \n\nLee, E., Lendas, K.A., Chow, S., Disease relevant HLA class II alleles isolated by genotypic, haplotypic, and sequence analysis in North American Caucasians with pemphigus vulgaris (2006) Hum Immunol, 67, pp. 125-139; \n\nWucherpfennig, K.W., Yu, B., Bhol, K., Structural basis for major histocompatibility complex (MHC)-linked susceptibility to autoimmunity: charged residues of a single MHC binding pocket confer selective presentation of self-peptides in pemphigus vulgaris (1995) Proc Natl Acad Sci USA, 92, pp. 11935-11939; \n\nCapon, F., Bharkhada, J., Cochrane, N.E., Evidence of an association between desmoglein 3 haplotypes and pemphigus vulgaris (2006) Br J Dermatol, 154, pp. 67-71; \n\nGibson, W.T., Walter, M.A., Ahmed, A.R., The immunoglobulin heavy chain and disease association: application to pemphigus vulgaris (1994) Hum Genet, 94, pp. 675-683; \n\nSlomov, E., Loewenthal, R., Korostishevsky, M., Pemphigus vulgaris is associated with the transporter associated with antigen processing (TAP) system (2005) Hum Immunol, 66, pp. 1213-1222; \n\nSami, N., Ahmed, A.R., Dual diagnosis of pemphigus and pemphigoid (2001) Retrospective review of thirty cases in the literature. Dermatology, 202, pp. 293-301; \n\nMemar, O.M., Rady, P.L., Goldblum, R.M., Human herpesvirus 8 DNA sequences in blistering skin from patients with pemphigus (1997) Arch Dermatol, 133, pp. 1247-1251; \n\nTufano, M., Baroni, A., Buommino, E., Detection of virus DNA in peripheral blood mononuclear cells and skin lesions of patients with pemphigus by polymerase chain reaction (1999) Br J Dermatol, 141, pp. 1033-1039; \n\nLateef, A., Packles, M.R., White, S.M., Pemphigus vegetans in association with human immunodeficiency virus (1999) Int J Dermatol, 38, pp. 778-781; \n\nValikhani, M., Kavusi, S., Chams-Davatchi, C., Pemphigus and associated environmental factors: a case-control study (2007) Clin Exp Dermatol, 32, pp. 256-260; \n\nStanley, J.R., Defective cell-cell adhesion in the epidermis (1995) Ciba Found Symp, 189, pp. 107-120. , discussion 20-3, 74-76; \n\nAmagai, M., Klaus-Kovtun, V., Stanley, J.R., Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion (1991) Cell, 67, pp. 869-877; \n\nAmagai, M., Karpati, S., Prussick, R., Autoantibodies against the amino-terminal cadherin-like binding domain of pemphigus vulgaris antigen are pathogenic (1992) J Clin Invest, 90, pp. 919-926; \n\nKarpati, S., Amagai, M., Prussick, R., Pemphigus vulgaris antigen, a desmoglein type of cadherin, is localized within keratinocyte desmosomes (1993) J Cell Biol, 122, pp. 409-415; \n\nBoulinguez, S., Bedane, C., Cadilhac, H., Ultrastructural localisation of pemphigus vulgaris and pemphigus foliaceus antigens by indirect immunoelectron microscopy (1995) Apropos of 7 cases. Ann Dermatol Venereol, 122, pp. 417-421; \n\nIwatsuki, K., Harada, H., Zhang, J.Z., Regulation of pemphigus and desmosomal antigen expression by keratinocyte differentiation (1994) Dermatology, 189 (SUPPL. 1), pp. 67-71; \n\nHashimoto, T., Amagai, M., Garrod, D.R., Immunofluorescence and immunoblot studies on the reactivity of pemphigus vulgaris and pemphigus foliaceus sera with desmoglein 3 and desmoglein 1 (1995) Epithelial Cell Biol, 4, pp. 63-69; \n\nShimizu, H., Masunaga, T., Ishiko, A., Pemphigus vulgaris and pemphigus foliaceus sera show an inversely graded binding pattern to extracellular regions of desmosomes in different layers of human epidermis (1995) J Invest Dermatol, 105, pp. 153-159; \n\nAmagai, M., Koch, P.J., Nishikawa, T., Pemphigus vulgaris antigen (desmoglein 3) is localized in the lower epidermis, the site of blister formation in patients (1996) J Invest Dermatol, 106, pp. 351-355; \n\nIoannides, D., Hytiroglou, P., Phelps, R.G., Regional variation in the expression of pemphigus foliaceus, pemphigus erythematosus, and pemphigus vulgaris antigens in human skin (1991) J Invest Dermatol, 96, pp. 159-161; \n\nShirakata, Y., Amagai, M., Hanakawa, Y., Lack of mucosal involvement in pemphigus foliaceus may be due to low expression of desmoglein 1 (1998) J Invest Dermatol, 110, pp. 76-78; \n\nBurge, S.M., Wilson, C.L., Dean, D., An immunohistological study of desmosomal components in pemphigus (1993) Br J Dermatol, 128, pp. 363-370; \n\nIshii, K., Amagai, M., Hall, R.P., Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins (1997) J Immunol, 159, pp. 2010-2017; \n\nDing, X., Aoki, V., Mascaro Jr, J.M., Mucosal and mucocutaneous (generalized) pemphigus vulgaris show distinct autoantibody profiles (1997) J Invest Dermatol, 109, pp. 592-596; \n\nAmagai, M., Tsunoda, K., Zillikens, D., The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile (1999) J Am Acad Dermatol, 40, pp. 167-170; \n\nMiyagawa, S., Amagai, M., Iida, T., Late development of antidesmoglein 1 antibodies in pemphigus vulgaris: correlation with disease progression (1999) Br J Dermatol, 141, pp. 1084-1087; \n\nIshii, K., Amagai, M., Ohata, Y., Development of pemphigus vulgaris in a patient with pemphigus foliaceus: antidesmoglein antibody profile shift confirmed by enzyme-linked immunosorbent assay (2000) J Am Acad Dermatol, 42, pp. 859-861; \n\nSami, N., Bhol, K.C., Ahmed, A.R., Diagnostic features of pemphigus vulgaris in patients with pemphigus foliaceus: detection of both autoantibodies, long-term follow-up and treatment responses (2001) Clin Exp Immunol, 125, pp. 492-498; \n\nKomai, A., Amagai, M., Ishii, K., The clinical transition between pemphigus foliaceus and pemphigus vulgaris correlates well with the changes in autoantibody profile assessed by an enzyme-linked immunosorbent assay (2001) Br J Dermatol, 144, pp. 1177-1182; \n\nTsuji, Y., Kawashima, T., Yokota, K., Clinical and serological transition from pemphigus vulgaris to pemphigus foliaceus demonstrated by desmoglein ELISA system (2002) Arch Dermatol, 138, pp. 95-96; \n\nHarman, K.E., Gratian, M.J., Shirlaw, P.J., The transition of pemphigus vulgaris into pemphigus foliaceus: a reflection of changing desmoglein 1 and 3 autoantibody levels in pemphigus vulgaris (2002) Br J Dermatol, 146, pp. 684-687; \n\nYoshida, K., Takae, Y., Saito, H., Cutaneous type pemphigus vulgaris: a rare clinical phenotype of pemphigus (2005) J Am Acad Dermatol, 52, pp. 839-845; \n\nHerrero-Gonzalez, J.E., Mascaro Jr, J.M., Iranzo, P., Atypical pemphigus: discordance between clinicopathological findings and the antigenic profile in four cases (2006) J Cutan Pathol, 33, pp. 502-507; \n\nOlszewska, M., Gerlicz, Z., Blaszczyk, M., Cutaneous pemphigus vulgaris (2007) J Eur Acad Dermatol Venereol, 21, pp. 698-699; \n\nWeitz, D., Bystryn, J.C., Frequency of shifts over time in the profile of antidesmoglein antibodies in pemphigus vulgaris (2007) Arch Dermatol, 143, pp. 1073-1074; \n\nDing, X., Diaz, L.A., Fairley, J.A., The anti-desmoglein 1 autoantibodies in pemphigus vulgaris sera are pathogenic (1999) J Invest Dermatol, 112, pp. 739-743; \n\nHarman, K.E., Gratian, M.J., Bhogal, B.S., A study of desmoglein 1 autoantibodies in pemphigus vulgaris: racial differences in frequency and the association with a more severe phenotype (2000) Br J Dermatol, 143, pp. 343-348; \n\nFitzpatrick, R., Newcomer, R., Correlation of disease activity and antibody titres in pemphigus (1980) Arch Dermatol, 116, pp. 285-290; \n\nHarman, K.E., Seed, P.T., Gratian, M.J., The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels (2001) Br J Dermatol, 144, pp. 775-780; \n\nCheng, S.W., Amagai, M., Nishikawa, T., Monitoring disease activity in pemphigus with enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3 (2002) Br J Dermatol, 147, pp. 261-265; \n\nRuach, M., Ohel, G., Rahav, D., Pemphigus vulgaris and pregnancy (1995) Obstet Gynecol Surv, 50, pp. 755-760; \n\nAnhalt, G.J., Labib, R.S., Voorhees, J.J., Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease (1982) N Engl J Med, 306, pp. 1189-1196; \n\nAmagai, M., Hashimoto, T., Shimizu, N., Absorption of pathogenic autoantibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus (1994) J Clin Invest, 94, pp. 59-67; \n\nMahoney, M.G., Wang, Z., Rothenberger, K., Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris (1999) J Clin Invest, 103, pp. 461-468; \n\nHertl, M., Humoral and cellular autoimmunity in autoimmune bullous skin disorders (2000) Int Arch Allergy Immunol, 122, pp. 91-100; \n\nBhol, K., Mohimen, A., Ahmed, A.R., Correlation of subclasses of IgG with disease activity in pemphigus vulgaris (1994) Dermatology, 189 (SUPPL. 1), pp. 85-89; \n\nBhol, K., Natarajan, K., Nagarwalla, N., Correlation of peptide specificity and IgG subclass with pathogenic and nonpathogenic autoantibodies in pemphigus vulgaris: a model for autoimmunity (1995) Proc Natl Acad Sci USA, 92, pp. 5239-5243; \n\nTsunoda, K., Ota, T., Aoki, M., Induction of pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 3 (2003) J Immunol, 170, pp. 2170-2178; \n\nMuller, R., Svoboda, V., Wenzel, E., IgG reactivity against non-conformational NH-terminal epitopes of the desmoglein 3 ectodomain relates to clinical activity and phenotype of pemphigus vulgaris (2006) Exp Dermatol, 15, pp. 606-614; \n\nDmochowski, M., Hashimoto, T., Garrod, D.R., Desmocollins I and II are recognized by certain sera from patients with various types of pemphigus, particularly Brazilian pemphigus foliaceus (1993) J Invest Dermatol, 100, pp. 380-384; \n\nHashimoto, T., Amagai, M., Watanabe, K., A case of pemphigus vulgaris showing reactivity with pemphigus antigens (Dsg1 and Dsg3) and desmocollins (1995) J Invest Dermatol, 104, pp. 541-544; \n\nEvangelista, F., Dasher, D.A., Diaz, L.A., E-cadherin is an additional immunological target for pemphigus autoantibodies (2008) J Invest Dermatol, 128, pp. 1710-1718; \n\nCozzani, E., Dal Bello, M.G., Mastrogiacomo, A., Antidesmoplakin antibodies in pemphigus vulgaris (2006) Br J Dermatol, 154, pp. 624-628; \n\nNguyen, V.T., Ndoye, A., Shultz, L.D., Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions (2000) J Clin Invest, 106, pp. 1467-1479; \n\nNguyen, V.T., Arredondo, J., Chernyavsky, A.I., Pemphigus vulgaris acantholysis ameliorated by cholinergic agonists (2004) Arch Dermatol, 140, pp. 327-334; \n\nStanley, J.R., Nishikawa, T., Diaz, L.A., Pemphigus: is there another half of the story? (2001) J Invest Dermatol, 116, pp. 489-490; \n\nAmagai, M., Ahmed, A.R., Kitajima, Y., Are desmoglein autoantibodies essential for the immunopathogenesis of pemphigus vulgaris, or just 'witnesses of disease'? (2006) Exp Dermatol, 15, pp. 815-831; \n\nLever, W., Pemphigus and Pemphigoid (1965), Springfield: ThomasBerkowitz, P., Hu, P., Warren, S., p38MAPK inhibition prevents disease in pemphigus vulgaris mice (2006) Proc Natl Acad Sci USA, 103, pp. 12855-12860; \n\nFrusic-Zlotkin, M., Pergamentz, R., Michel, B., The interaction of pemphigus autoimmunoglobulins with epidermal cells: activation of the fas apoptotic pathway and the use of caspase activity for pathogenicity tests of pemphigus patients (2005) Ann N Y Acad Sci, 1050, pp. 371-379; \n\nKawana, S., Geoghegan, W.D., Jordon, R.E., Deposition of the membrane attack complex of complement in pemphigus vulgaris and pemphigus foliaceus skin (1989) J Invest Dermatol, 92, pp. 588-592; \n\nAnhalt, G.J., Till, G.O., Diaz, L.A., Defining the role of complement in experimental pemphigus vulgaris in mice (1986) J Immunol, 137, pp. 2835-2840; \n\nSchiltz, J.R., Michel, B., Production of epidermal acantholysis in normal human skin in vitro by the IgG fraction from pemphigus serum (1976) J Invest Dermatol, 67, pp. 254-260; \n\nGrando, S.A., Glukhenky, B.T., Drannik, G.N., Mediators of inflammation in blister fluids from patients with pemphigus vulgaris and bullous pemphigoid (1989) Arch Dermatol, 125, pp. 925-930; \n\nZillikens, D., Ambach, A., Zentner, A., Evidence for cell-mediated immune mechanisms in the pathology of pemphigus (1993) Br J Dermatol, 128, pp. 636-643; \n\nFeliciani, C., Toto, P., Amerio, P., In vitro C3 mRNA expression in Pemphigus vulgaris: complement activation is increased by IL-1alpha and TNF-alpha (1999) J Cutan Med Surg, 3, pp. 140-144; \n\nMorioka, S., Lazarus, G., Jensen, P., Involvement of urokinase type plasminogen activator in acantholysis induced by pemphigus IgG (1987) J Invest Dermatol, 89, pp. 474-477; \n\nReinhartz, J., Naher, H., Mai, H., Plasminogen activation in lesional skin of pemphigus vulgaris type Neumann (1993) Arch Dermatol Res, 284, pp. 432-439; \n\nFeliciani, C., Toto, P., Wang, B., Urokinase plasminogen activator mRNA is induced by IL-1alpha and TNF-alpha in in vitro acantholysis (2003) Exp Dermatol, 12, pp. 466-471; \n\nLopez-Robles, E., Avalos-Diaz, E., Vega-Memije, E., TNFalpha and IL-6 are mediators in the blistering process of pemphigus (2001) Int J Dermatol, 40, pp. 185-188; \n\nJacobi, A., Shuler, G., Hertl, M., Rapid control of therapy-refractory pemphigus vulgaris by treatment with the tumour necrosis factor-alpha inhibitor infliximab (2005) Br J Dermatol, 153, pp. 448-449; \n\nHashimoto, K., Wun, T.-C., Baird, J., Characterization of keratinocyte plasminogen activator inhibitors and demonstration of the prevention of pemphigus IgG induced acantholysis by a purified plasminogen activator inhibitor (1989) J Invest Dermatol, 92, pp. 310-315; \n\nMahoney, M.G., Wang, Z.H., Stanley, J.R., Pemphigus vulgaris and pemphigus foliaceus antibodies are pathogenic in plasminogen activator knockout mice (1999) J Invest Dermatol, 113, pp. 22-25; \n\nAnhalt, G.J., Patel, H.P., Labib, R.S., Dexamethasone inhibits plasminogen activator activity in experimental pemphigus in vivo but does not block acantholysis (1986) J Immunol, 136, pp. 113-117; \n\nTakahashi, Y., Patel, H.P., Labib, R.S., Experimentally induced pemphigus vulgaris in neonatal BALB/c mice: a time-course study of clinical, immunologic, ultrastructural, and cytochemical changes (1985) J Invest Dermatol, 84, pp. 41-46; \n\nLever, W., Pemphigus and Pemphigoid (1965), Springfield: ThomasHashimoto, K., Lever, W.F., An ultrastructural study of cell junctions in pemphigus vulgaris (1970) Arch Dermatol, 101, pp. 287-298; \n\nTakahashi, Y., Patel, H.P., Labib, R.S., Experimentally induced pemphigus vulgaris in neonatal BALB/c mice: a time-course study of clinical, immunologic, ultrastructural, and cytochemical changes (1985) J Invest Dermatol, 84, pp. 41-46; \n\nHelander, S.D., Rogers III, R.S., The sensitivity and specificity of direct immunofluorescence testing in disorders of mucous membranes (1994) J Am Acad Dermatol, 30, pp. 65-75; \n\nHarman, K.E., Gratian, M.J., Bhogal, B.S., The use of two substrates to improve the sensitivity of indirect immunofluorescence in the diagnosis of pemphigus (2000) Br J Dermatol, 142, pp. 1135-1139; \n\nIshii, K., Amagai, M., Hall, R.P., Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins (1997) J Immunol, 159, pp. 2010-2017; \n\nAmagai, M., Komai, A., Hashimoto, T., Usefulness of enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus (1999) Br J Dermatol, 140, pp. 351-357; \n\nCheng, S.W., Amagai, M., Nishikawa, T., Monitoring disease activity in pemphigus with enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3 (2002) Br J Dermatol, 147, pp. 261-265; \n\nAhmed, A., Workman, A., Anti-intercellular substance antibody: presence in serum of 14 patients without pemphigus (1983) Arch Dermatol, 119, pp. 17-21; \n\nThivolet, J., Beyvin, A., Recherche par immunofluorescence d'anticorps seriques vis-vis des constituants de l'epiderme chez les brutes (1968) Experientia, 24, pp. 945-946; \n\nFellner, M.J., Mark, A.S., Penicillin-and ampicillin-induced pemphigus vulgaris (1980) Int J Dermatol, 19, pp. 392-393; \n\nAnzai, H., Stanley, J.R., Amagai, M., Production of low titers of anti-desmoglein 1 IgG autoantibodies in some patients with staphylococcal scalded skin syndrome (2006) J Invest Dermatol, 126, pp. 2139-2141; \n\nAhmed, A.R., Mohimen, A., Yunis, E.J., Linkage of pemphigus vulgaris antibody to the major histocompatibility complex in healthy relatives of patients (1993) J Exp Med, 177, pp. 419-424; \n\nKricheli, D., David, M., Frusic-Zlotkin, M., The distribution of pemphigus vulgaris-IgG subclasses and their reactivity with desmoglein 3 and 1 in pemphigus patients and their first-degree relatives (2000) Br J Dermatol, 143, pp. 337-342; \n\nKrain, L.S., Pemphigu (1974) Epidemiologic and survival characteristics of 59 patients, 1955-1973. Arch Dermatol, 110, pp. 862-865; \n\nRosenberg, F.R., Sanders, S., Nelson, C.T., Pemphigus: a 20-year review of 107 patients treated with corticosteroids (1976) Arch Dermatol, 112, pp. 962-970; \n\nRyan, J.G., Pemphigu (1971) A 20-year survey of experience with 70 cases. Arch Dermatol, 104, pp. 14-20; \n\nZegarelli, D.J., Zegarelli, E.V., Intraoral pemphigus vulgaris (1977) Oral Surg Oral Med Oral Pathol, 44, pp. 384-393; \n\nHodak, E., Kremer, I., David, M., Conjunctival involvement in pemphigus vulgaris: a clinical, histopathological and immunofluorescence study (1990) Br J Dermatol, 123, pp. 615-620; \n\nHale, E.K., Bystryn, J.C., Laryngeal and nasal involvement in pemphigus vulgaris (2001) J Am Acad Dermatol, 44, pp. 609-611; \n\nLurie, R., Trattner, A., David, M., Esophageal involvement in pemphigus vulgaris: report of two cases and review of the literature (1990) Dermatologica, 181, pp. 233-236; \n\nTrattner, A., Lurie, R., Leiser, A., Esophageal involvement in pemphigus vulgaris: a clinical, histologic, and immunopathologic study (1991) J Am Acad Dermatol, 24, pp. 223-226; \n\nMarren, P., Wojnarowska, F., Venning, V., Vulvar involvement in autoimmune bullous diseases (1993) J Reprod Med, 38, pp. 101-107; \n\nSagher, F., Bercovici, B., Romem, R., Nikolsky sign on cervix uteri in pemphigus (1974) Br J Dermatol, 90, pp. 407-411; \n\nLapiere, K., Caers, S., Lambert, J., A case of long-lasting localized pemphigus vulgaris of the scalp (2004) Dermatology, 209, pp. 162-163; \n\nYesudian, P.D., Krishnan, S.G., Jayaraman, M., Postpemphigus acanthomata: a sign of clinical activity? (1997) Int J Dermatol, 36, pp. 194-196; \n\nBerker, D.D., Dalziel, K., Dawber, R.P., Pemphigus associated with nail dystrophy (1993) Br J Dermatol, 129, pp. 461-464; \n\nKolivras, A., Gheeraert, P., Andre, J., Nail destruction in pemphigus vulgaris (2003) Dermatology, 206, pp. 351-352; \n\nNagasaka, A., Matsue, H., Miyahara, A., Pemphigus vulgaris with no mucosal lesions showing pemphigus-foliaceus-like skin manifestations: Is there a 'cutaneous type' of pemphigus vulgaris? (2005) Dermatology, 211, pp. 372-374; \n\nYoshida, K., Takae, Y., Saito, H., Cutaneous type pemphigus vulgaris: a rare clinical phenotype of pemphigus (2005) J Am Acad Dermatol, 52, pp. 839-845; \n\nGoldberg, N.S., DeFeo, C., Kirshenbaum, N., Pemphigus vulgaris and pregnancy: risk factors and recommendations (1993) J Am Acad Dermatol, 28, pp. 877-879; \n\nHern, S., Vaughan Jones, S.A., Setterfield, J., Pemphigus vulgaris in pregnancy with favourable foetal prognosis (1998) Clin Exp Dermatol, 23, pp. 260-263; \n\nChowdhury, M.M., Natarajan, S., Neonatal pemphigus vulgaris associated with mild oral pemphigus vulgaris in the mother during pregnancy (1998) Br J Dermatol, 139, pp. 500-503; \n\nBjarnason, B., Flosadottir, E., Childhood, neonatal, and stillborn pemphigus vulgaris (1999) Int J Dermatol, 38, pp. 680-688; \n\nAhmed, A.R., Moy, R., Death in pemphigus (1982) J Am Acad Dermatol, 7, pp. 221-228; \n\nCarson, P.J., Hameed, A., Ahmed, A.R., Influence of treatment on the clinical course of pemphigus vulgaris (1996) J Am Acad Dermatol, 34, pp. 645-652; \n\nSavin, J.A., Some factors affecting prognosis in pemphigus vulgaris and pemphigoid (1981) Br J Dermatol, 104, pp. 415-420; \n\nMourellou, O., Chaidemenos, G.C., Koussidou, T., The treatment of pemphigus vulgari (1995) Experience with 48 patients seen over an 11-year period. Br J Dermatol, 133, pp. 83-87; \n\nStamm, C., Thivolet, J., Weaning of systemic steroid treatment in pemphigus: a twelve year retrospective study on 270 French patients (1995) Eur J Dermatol, 5, pp. 664-670; \n\nKyriakis, K.P., Tosca, A.D., Epidemiologic observations on the natural course of pemphigus vulgaris (1998) Int J Dermatol, 37, pp. 215-219; \n\nAhmed, A.R., Blose, D.A., Pemphigus vegetans (1984) Neumann type and Hallopeau type. Int J Dermatol, 23, pp. 135-141; \n\nParodi, A., Stanley, J.R., Ciaccio, M., Epidermal antigens in pemphigus vegetans (1988) Report of a case. Br J Dermatol, 119, pp. 799-802; \n\nHashizume, H., Iwatsuki, K., Takigawa, M., Epidermal antigens and complementbinding anti-intercellular antibodies in pemphigus vegetans, Hallopeau type (1993) Br J Dermatol, 129, pp. 739-743; \n\nOhata, Y., Komiya, H., Kawahara, Y., A case of Neumann type pemphigus vegetans showing reactivity with the 130 kD pemphigus vulgaris antigen (1996) Acta Derm Venereol, 76, pp. 169-170; \n\nOhata, Y., Hashimoto, T., Nishikawa, T., Comparative study of autoantigens for various bullous skin diseases by immunoblotting using different dermo-epidermal separation techniques (1995) Clin Exp Dermatol, 20, pp. 454-458; \n\nArnold, J., Rose, C., Amagai, M., Pemphigus vegetans with autoantibodies directed against recombinant desmoglein 3 (2000) Aktuelle Dermatologie, 26, pp. 241-244; \n\nHashimoto, K., Hashimoto, T., Higashiyama, M., Detection of anti-desmocollins I and II autoantibodies in two cases of Hallopeau type pemphigus vegetans by immunoblot analysis (1994) J Dermatol Sci, 7, pp. 100-106; \n\nLever, W., Pemphigus and Pemphigoid (1965), Springfield: ThomasCecchi, R., Tuci, F., Brunetti, L., Pemphigus vegetans of Hallopeau following pemphigus foliaceus (1994) J Eur Acad Dermatol Venereol, 3, pp. 67-70; \n\nHelander, S.D., Rogers III, R.S., The sensitivity and specificity of direct immunofluorescence testing in disorders of mucous membranes (1994) J Am Acad Dermatol, 30, pp. 65-75; \n\nJones, S.A.V., Sales, J., McGrath, J., A retrospective analysis of tissue fixed immunoreactants from skin biopsies maintained in Michel's medium (1994) Dermatology, 189, pp. 131-132; \n\nWeston, W.L., Friednash, M., Hashimoto, T., A novel childhood pemphigus vegetans variant of intraepidermal neutrophilic IgA dermatosis (1998) J Am Acad Dermatol, 38, pp. 635-638; \n\nSapadin, A.N., Anhalt, G.J., Paraneoplastic pemphigus with a pemphigus vegetanslike plaque as the only cutaneous manifestation (1998) J Am Acad Dermatol, 39, pp. 867-871; \n\nVenning, V., Burge, S., Dalziel, K., Pemphigus vegetans masquerading as multiple squamous cell carcinoma (1990) Br J Dermatol, 123 (SUPPL. 37), pp. 112-113; \n\nCrotty, C., Pittelkow, M., Muller, S.A., Eosinophilic spongiosis: a clinicopathologic review of seventy-one cases (1983) J Am Acad Dermatol, 8, pp. 337-343; \n\nRosenberg, F.R., Sanders, S., Nelson, C.T., Pemphigus: a 20-year review of 107 patients treated with corticosteroids (1976) Arch Dermatol, 112, pp. 962-970; \n\nBystryn, J.C., Steinman, N.M., The adjuvant therapy of pemphigus (1996) An update. Arch Dermatol, 132, pp. 203-212; \n\nCarson, P.J., Hameed, A., Ahmed, A.R., Influence of treatment on the clinical course of pemphigus vulgaris (1996) J Am Acad Dermatol, 34, pp. 645-652; \n\nDick, S.E., Werth, V.P., Pemphigus: a treatment update (2006) Autoimmunity, 39, pp. 591-599; \n\nCheng, S.W., Amagai, M., Nishikawa, T., Monitoring disease activity in pemphigus with enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3 (2002) Br J Dermatol, 147, pp. 261-265; \n\nO'Loughlin, S., Goldman, G.C., Provost, T.T., Fate of pemphigus antibody following successful therapy (1978) Preliminary evaluation of pemphigus antibody determinations to regulate therapy. Arch Dermatol, 114, pp. 1769-1772; \n\nIraji, F., Yoosefi, A., Healing effect of Pilocarpine gel 4% on skin lesions of pemphigus vulgaris (2006) Int J Dermatol, 45, pp. 743-746; \n\nChrysomallis, F., Ioannides, D., Teknetzis, A., Treatment of oral pemphigus vulgaris (1994) Int J Dermatol, 33, pp. 803-807; \n\nStamm, C., Thivolet, J., Weaning of systemic steroid treatment in pemphigus: a twelve year retrospective study on 270 French patients (1995) Eurpean J Dermatol, 5, pp. 664-670; \n\nBystryn, J.C., Adjuvant therapy of pemphigus (1984) Arch Dermatol, 120, pp. 941-951; \n\nMourellou, O., Chaidemenos, G.C., Koussidou, T., The treatment of pemphigus vulgari (1995) Experience with 48 patients seen over an 11-year period. Br J Dermatol, 133, pp. 83-87; \n\nPasricha, J.S., Khaitan, B.K., Raman, R.S., Dexamethasone-cyclophosphamide pulse therapy for pemphigus (1995) Int J Dermatol, 34, pp. 875-882; \n\nChryssomallis, F., Dimitriades, A., Chaidemenos, G.C., Steroid-pulse therapy in pemphigus vulgaris long term follow-up (1995) Int J Dermatol, 34, pp. 438-442; \n\nHuilgol, S.C., Black, M.M., Management of the immunobullous disorders (1995) II. Pemphigus. Clin Exp Dermatol, 20, pp. 283-293; \n\nAberer, W., Wolff-Schreiner, E.C., Stingl, G., Azathioprine in the treatment of pemphigus vulgaris (1987) A long-term follow-up. J Am Acad Dermatol, 16, pp. 527-533; \n\nPandya, A.G., Sontheimer, R.D., Treatment of pemphigus vulgaris with pulse intravenous cyclophosphamide (1992) Arch Dermatol, 128, pp. 1626-1630; \n\nChams-Davatchi, C., Esmaili, N., Daneshpazhooh, M., Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris (2007) J Am Acad Dermatol, 57, pp. 622-628; \n\nBeissert, S., Werfel, T., Frieling, U., A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus (2006) Arch Dermatol, 142, pp. 1447-1454; \n\nPiamphongsant, T., Ophaswongse, S., Treatment of pemphigus (1991) Int J Dermatol, 30, pp. 139-146; \n\nKanwar, A.J., Kaur, S., Thami, G.P., Long-term efficacy of dexamethasone-cyclophosphamide pulse therapy in pemphigus (2002) Dermatology, 204, pp. 228-231; \n\nEnk, A.H., Knop, J., Mycophenolate is effective in the treatment of pemphigus vulgaris (1999) Arch Dermatol, 135, pp. 54-56; \n\nMimouni, D., Anhalt, G.J., Cummins, D.L., Treatment of pemphigus vulgaris and pemphigus foliaceus with mycophenolate mofetil (2003) Arch Dermatol, 139, pp. 739-742; \n\nPowell, A.M., Albert, S., Al Fares, S., An evaluation of the usefulness of mycophenolate mofetil in pemphigus (2003) Br J Dermatol, 149, pp. 138-145; \n\nChaffins, M.L., Collison, D., Fivenson, D.P., Treatment of pemphigus and linear IgA dermatosis with nicotinamide and tetracycline: a review of 13 cases (1993) J Am Acad Dermatol, 28, pp. 998-1000; \n\nCalebotta, A., Saenz, A.M., Gonzalez, F., Pemphigus vulgaris: benefits of tetracycline as adjuvant therapy in a series of thirteen patients (1999) Int J Dermatol, 38, pp. 217-221; \n\nBarthelemy, H., Frappaz, A., Cambazard, F., Treatment of nine cases of pemphigus vulgaris with cyclosporine (1988) J Am Acad Dermatol, 18, pp. 1262-1266; \n\nCampolmi, P., Bonan, P., Lotti, T., The role of cyclosporine A in the treatment of pemphigus erythematosus (1991) Int J Dermatol, 30, pp. 890-892; \n\nLapidoth, M., David, M., Ben-Amitai, D., The efficacy of combined treatment with prednisone and cyclosporine in patients with pemphigus: preliminary study (1994) J Am Acad Dermatol, 30, pp. 752-757; \n\nIoannides, D., Chrysomallis, F., Bystryn, J.C., Ineffectiveness of cyclosporine as an adjuvant to corticosteroids in the treatment of pemphigus (2000) Arch Dermatol, 136, pp. 868-872; \n\nGooptu, C., Staughton, R.C., Use of topical cyclosporin in oral pemphigus (1998) J Am Acad Dermatol, 38, pp. 860-861; \n\nBasset, N., Guillot, B., Michel, B., Dapsone as initial treatment in superficial pemphigus (1987) Report of nine cases. Arch Dermatol, 123, pp. 783-785; \n\nWerth, V.P., Fivenson, D., Pandya, A.G., Multicenter randomized, double-blind, placebo-controlled, clinical trial of dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris (2008) Arch Dermatol, 144, pp. 25-32; \n\nSmith, T.J., Bystryn, J.C., Methotrexate as an adjuvant treatment for pemphigus vulgaris (1999) Arch Dermatol, 135, pp. 1275-1276; \n\nSchmidt, E., Seitz, C.S., Benoit, S., Rituximab in autoimmune bullous diseases: mixed responses and adverse effects (2007) Br J Dermatol, 156, pp. 352-356; \n\nGoh, M.S., McCormack, C., Dinh, H.V., Rituximab in the adjuvant treatment of pemphigus vulgaris: a prospective open-label pilot study in five patients (2007) Br J Dermatol, 156, pp. 990-996; \n\nLuftl, M., Stauber, A., Mainka, A., Successful removal of pathogenic autoantibodies in pemphigus by immunoadsorption with a tryptophan-linked polyvinylalcohol adsorber (2003) Br J Dermatol, 149, pp. 598-605; \n\nShimanovich, I., Herzog, S., Schmidt, E., Improved protocol for treatment of pemphigus vulgaris with protein A immunoadsorption (2006) Clin Exp Dermatol, 31, pp. 768-774; \n\nHarman, K.E., Black, M.M., High-dose intravenous immune globulin for the treatment of autoimmune blistering diseases: an evaluation of its use in 14 cases (1999) Br J Dermatol, 140, pp. 865-874; \n\nEngineer, L., Bhol, K.C., Ahmed, A.R., Analysis of current data on the use of intravenous immunoglobulins in management of pemphigus vulgaris (2000) J Am Acad Dermatol, 43, pp. 1049-1057; \n\nBaum, S., Scope, A., Barzilai, A., The role of IVIg treatment in severe pemphigus vulgaris (2006) J Eur Acad Dermatol Venereol, 20, pp. 548-552; \n\nIchimiya, M., Yamamoto, K., Muto, M., Successful treatment of pemphigus vegetans by addition of etretinate to systemic steroids (1998) Clin Exp Dermatol, 23, pp. 178-180; \n\nJacobi, A., Shuler, G., Hertl, M., Rapid control of therapy-refractory pemphigus vulgaris by treatment with the tumour necrosis factor-alpha inhibitor infliximab (2005) Br J Dermatol, 153, pp. 448-449; \n\nBerookhim, B., Fischer, H.D., Weinberg, J.M., Treatment of recalcitrant pemphigus vulgaris with the tumor necrosis factor alpha antagonist etanercept (2004) Cutis, 74, pp. 245-247; \n\nRyan, J.G., Pemphigu (1971) A 20-year survey of experience with 70 cases. Arch Dermatol, 104, pp. 14-20; \n\nBeutner, E.H., Chorzelski, T.P., Studies on etiologic factors in pemphigus (1976) J Cutan Pathol, 3, pp. 67-74; \n\nRosenberg, F.R., Sanders, S., Nelson, C.T., Pemphigus: a 20-year review of 107 patients treated with corticosteroids (1976) Arch Dermatol, 112, pp. 962-970; \n\nKrain, L.S., Pemphigu (1974) Epidemiologic and survival characteristics of 59 patients, 1955-1973. Arch Dermatol, 110, pp. 862-865; \n\nWilson, C., Wojnarowska, F., Mehra, N.K., Pemphigus in Oxford, UK, and New Delhi, India: a comparative study of disease characteristics and HLA antigens (1994) Dermatology, 189 (SUPPL. 1), pp. 108-110; \n\nDiaz, L.A., Sampaio, S.A., Rivitti, E.A., Endemic pemphigus foliaceus (fogo selvagem) (1989) I. Clinical features and immunopathology. J Am Acad Dermatol, 20, pp. 657-669; \n\nBastuji-Garin, S., Souissi, R., Blum, L., Comparative epidemiology of pemphigus in Tunisia and France: unusual incidence of pemphigus foliaceus in young Tunisian women (1995) J Invest Dermatol, 104, pp. 302-305; \n\nMahe, A., Flageul, B., Cisse, I., Pemphigus in Mali: a study of 30 cases (1996) Br J Dermatol, 134, pp. 114-119; \n\nAboobaker, J., Morar, N., Ramdial, P.K., Pemphigus in South Africa (2001) Int J Dermatol, 40, pp. 115-119; \n\nTron, F., Gilbert, D., Mouquet, H., Genetic factors in pemphigus (2005) J Autoimmun, 24, pp. 319-328; \n\nStanley, J.R., Klaus-Kovtun, V., Sampaio, S.A., Antigenic specificity of fogo selvagem autoantibodies is similar to North American pemphigus foliaceus and distinct from pemphigus vulgaris autoantibodies (1986) J Invest Dermatol, 87, pp. 197-201; \n\nAllen, E.M., Giudice, G.J., Diaz, L.A., Subclass reactivity of pemphigus foliaceus autoantibodies with recombinant human desmoglein (1993) J Invest Dermatol, 100, pp. 685-691; \n\nDmochowski, M., Hashimoto, T., Amagai, M., The extracellular aminoterminal domain of bovine desmoglein 1 (Dsg1) is recognized only by certain pemphigus foliaceus sera, whereas its intracellular domain is recognized by both pemphigus vulgaris and pemphigus foliaceus sera (1994) J Invest Dermatol, 103, pp. 173-177; \n\nOlague-Alcala, M., Giudice, G.J., Diaz, L.A., Pemphigus foliaceus sera recognize an N-terminal fragment of bovine desmoglein 1 (1994) J Invest Dermatol, 102, pp. 882-885; \n\nAkiyama, M., Hashimoto, T., Sugiura, M., Ultrastructural localization of Brazilian pemphigus foliaceus (fogo selvagem) antigens in cultured human squamous cell carcinoma cells (1993) Br J Dermatol, 128, pp. 378-383; \n\nIshii, K., Amagai, M., Ohata, Y., Development of pemphigus vulgaris in a patient with pemphigus foliaceus: antidesmoglein antibody profile shift confirmed by enzyme-linked immunosorbent assay (2000) J Am Acad Dermatol, 42, pp. 859-861; \n\nTsuji, Y., Kawashima, T., Yokota, K., Clinical and serological transition from pemphigus vulgaris to pemphigus foliaceus demonstrated by desmoglein ELISA system (2002) Arch Dermatol, 138, pp. 95-96; \n\nHarman, K.E., Gratian, M.J., Shirlaw, P.J., The transition of pemphigus vulgaris into pemphigus foliaceus: a reflection of changing desmoglein 1 and 3 autoantibody levels in pemphigus vulgaris (2002) Br J Dermatol, 146, pp. 684-687; \n\nSami, N., Bhol, K.C., Ahmed, A.R., Diagnostic features of pemphigus vulgaris in patients with pemphigus foliaceus: detection of both autoantibodies, long-term follow-up and treatment responses (2001) Clin Exp Immunol, 125, pp. 492-498; \n\nKomai, A., Amagai, M., Ishii, K., The clinical transition between pemphigus foliaceus and pemphigus vulgaris correlates well with the changes in autoantibody profile assessed by an enzyme-linked immunosorbent assay (2001) Br J Dermatol, 144, pp. 1177-1182; \n\nMuller, E., Kernland, K., Caldelari, R., Unusual pemphigus phenotype in the presence of a Dsg1 and Dsg3 autoantibody profile (2002) J Invest Dermatol, 118, pp. 551-555; \n\nArteaga, L.A., Prisayanh, P.S., Warren, S.J., A subset of pemphigus foliaceus patients exhibits pathogenic autoantibodies against both desmoglein-1 and desmoglein-3 (2002) J Invest Dermatol, 118, pp. 806-811; \n\nDmochowski, M., Hashimoto, T., Garrod, D.R., Desmocollins I and II are recognized by certain sera from patients with various types of pemphigus, particularly Brazilian pemphigus foliaceus (1993) J Invest Dermatol, 100, pp. 380-384; \n\nDmochowski, M., Hashimoto, T., Chidgey, M.A., Demonstration of antibodies to bovine desmocollin isoforms in certain pemphigus sera (1995) Br J Dermatol, 133, pp. 519-525; \n\nJiao, D., Bystryn, J.C., Sensitivity of indirect immunofluorescence, substrate specificity, and immunoblotting in the diagnosis of pemphigus (1997) J Am Acad Dermatol, 37, pp. 211-216; \n\nNguyen, V.T., Ndoye, A., Shultz, L.D., Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions (2000) J Clin Invest, 106, pp. 1467-1479; \n\nRappersberger, K., Roos, N., Stanley, J.R., Immunomorphologic and biochemical identification of the pemphigus foliaceous autoantigen within desmosomes (1992) J Invest Dermatol, 99, pp. 323-330; \n\nBoulinguez, S., Bedane, C., Cadilhac, H., [Ultrastructural localisation of pemphigus vulgaris and pemphigus foliaceus antigens by indirect immunoelectron microscopy (1995) Apropos of 7 cases]. Ann Dermatol Venereol, 122, pp. 417-421; \n\nIoannides, D., Hytiroglou, P., Phelps, R.G., Regional variation in the expression of pemphigus foliaceus, pemphigus erythematosus, and pemphigus vulgaris antigens in human skin (1991) J Invest Dermatol, 96, pp. 159-161; \n\nIwatsuki, K., Harada, H., Zhang, J.Z., Regulation of pemphigus and desmosomal antigen expression by keratinocyte differentiation (1994) Dermatology, 189 (SUPPL. 1), pp. 67-71; \n\nShimizu, H., Masunaga, T., Ishiko, A., Pemphigus vulgaris and pemphigus foliaceus sera show an inversely graded binding pattern to extracellular regions of desmosomes in different layers of human epidermis (1995) J Invest Dermatol, 105, pp. 153-159; \n\nShirakata, Y., Amagai, M., Hanakawa, Y., Lack of mucosal involvement in pemphigus foliaceus may be due to low expression of desmoglein 1 (1998) J Invest Dermatol, 110, pp. 76-78; \n\nStanley, J.R., Defective cell-cell adhesion in the epidermis (1995) Ciba Found Symp, 189, pp. 107-120. , discussion 20-3, 74-76; \n\nSquiquera, H.L., Diaz, L.A., Sampaio, S.A., Serologic abnormalities in patients with endemic pemphigus foliaceus (Fogo selvagem), their relatives, and normal donors from endemic and non-endemic areas of Brazil (1988) J Invest Dermatol, 91, pp. 189-191; \n\nWarren, S.J., Lin, M.S., Giudice, G.J., The prevalence of antibodies against desmoglein 1 in endemic pemphigus foliaceus in Brazil (2000) Cooperative Group on Fogo Selvagem Research. N Engl J Med, 343, pp. 23-30; \n\nAmagai, M., Non-pathogenic anti-desmoglein 3 IgG autoantibodues in Fogo Selvagem (2006) J Invest Dermatol, 126, pp. 1931-1932; \n\nRock, B., Labib, R.S., Diaz, L.A., Monovalent Fab′ immunoglobulin fragments from endemic pemphigus foliaceus autoantibodies reproduce the human disease in neonatal Balb/c mice (1990) J Clin Invest, 85, pp. 296-299; \n\nCalvanico, N.J., Swartz, S.J., Diaz, L.A., Affinity immunoblotting studies on the restriction of autoantibodies from endemic pemphigus foliaceus patients (1993) J Autoimmun, 6, pp. 145-157; \n\nBurge, S.M., Wilson, C.L., Dean, D., An immunohistological study of desmosomal components in pemphigus (1993) Br J Dermatol, 128, pp. 363-370; \n\nCarlotti, A., Balaton, A.J., De Muret, A., Autoimmune pemphigus (1993) A distinct staining pattern with an anti-desmoglein antibody. Arch Dermatol, 129, pp. 596-599; \n\nRock, B., Martins, C.R., Theofilopoulos, A.N., The pathogenic effect of IgG4 autoantibodies in endemic pemphigus foliaceus (fogo selvagem) (1989) N Engl J Med, 320, pp. 1463-1469; \n\nAmagai, M., Hashimoto, T., Green, K.J., Antigen-specific immunoadsorption of pathogenic autoantibodies in pemphigus foliaceus (1995) J Invest Dermatol, 104, pp. 895-901; \n\nMorioka, S., Lazarus, G., Jensen, P., Involvement of urokinase type plasminogen activator in acantholysis induced by pemphigus IgG (1987) J Invest Dermatol, 89, pp. 474-477; \n\nCrotty, C., Pittelkow, M., Muller, S.A., Eosinophilic spongiosis: a clinicopathologic review of seventy-one cases (1983) J Am Acad Dermatol, 8, pp. 337-343; \n\nHoss, D.M., Shea, C.R., Grant-Kels, J.M., Neutrophilic spongiosis in pemphigus (1996) Arch Dermatol, 132, pp. 315-318; \n\nMatsuo, K., Komai, A., Ishii, K., Pemphigus foliaceus with prominent neutrophilic pustules (2001) Br J Dermatol, 145, pp. 132-136; \n\nWilgram, G., Caulfield, J., Madgic, M., An electron microscopic study of acantholysis and dyskeratosis in pemphigus foliaceous (1964) J Invest Dermatol, 43, pp. 287-299; \n\nRodriguez, J., Bystryn, J.C., Pemphigus foliaceus associated with absence of intercellular antigens in lower layers of epidermis (1977) Arch Dermatol, 113, pp. 1696-1699; \n\nBeutner, E.H., Chorzelski, T.P., Wilson, R.M., IgA pemphigus foliaceus (1989) Report of two cases and a review of the literature. J Am Acad Dermatol, 20, pp. 89-97; \n\nJiao, D., Bystryn, J.C., Sensitivity of indirect immunofluorescence, substrate specificity, and immunoblotting in the diagnosis of pemphigus (1997) J Am Acad Dermatol, 37, pp. 211-216; \n\nLever, W., Pemphigus and Pemphigoid (1965), Springfield: ThomasRocha-Alvarez, R., Friedman, H., Campbell, I.T., Pregnant women with endemic pemphigus foliaceus (Fogo Selvagem) give birth to disease-free babies (1992) J Invest Dermatol, 99, pp. 78-82; \n\nWalker, D.C., Kolar, K.A., Hebert, A.A., Neonatal pemphigus foliaceus (1995) Arch Dermatol, 131, pp. 1308-1311; \n\nAvalos-Diaz, E., Olague-Marchan, M., Lopez-Swiderski, A., Transplacental passage of maternal pemphigus foliaceus autoantibodies induces neonatal pemphigus (2000) J Am Acad Dermatol, 43, pp. 1130-1134; \n\nJablonska, S., Chorzelski, T.P., Beutner, E.H., Herpetiform pemphigus, a variable pattern of pemphigus (1975) Int J Dermatol, 14, pp. 353-359; \n\nRobinson, N.D., Hashimoto, T., Amagai, M., The new pemphigus variants (1999) J Am Acad Dermatol, 40, pp. 649-671; \n\nSanti, C.G., Maruta, C.W., Aoki, V., Pemphigus herpetiformis is a rare clinical expression of nonendemic pemphigus foliaceus, fogo selvagem, and pemphigus vulgaris (1996) Cooperative Group on Fogo Selvagem Research. J Am Acad Dermatol, 34, pp. 40-46; \n\nIshii, K., Amagai, M., Komai, A., Desmoglein 1 and desmoglein 3 are the target autoantigens in herpetiform pemphigus (1999) Arch Dermatol, 135, pp. 943-947; \n\nKubo, A., Amagai, M., Hashimoto, T., Herpetiform pemphigus showing reactivity with pemphigus vulgaris antigen (desmoglein 3) (1997) Br J Dermatol, 137, pp. 109-113; \n\nSenear, F., Usher, B., An unusual type of pemphigus (1926) Arch Dermatol, 13, pp. 761-781; \n\nMaize, J., Green, D., Provost, T., Pemphigus foliaceus: a case with serological features of Senear-Usher syndrome and other autoimmune abnormalities (1982) J Am Acad Dermatol, 7, pp. 736-741; \n\nAmerican, M., Ahmed, A., Pemphigus erythematosus (1985) Int J Dermatol, 24, pp. 16-25; \n\nJordon, R.E., Pemphigus erythematosus (1982) Arch Dermatol, 118, p. 742; \n\nGomi, H., Kawada, A., Amagai, M., Pemphigus erythematosus: detection of anti-desmoglein-1 antibodies by ELISA (1999) Dermatology, 199, pp. 188-189; \n\nCruz Jr, P.D., Coldiron, B.M., Sontheimer, R.D., Concurrent features of cutaneous lupus erythematosus and pemphigus erythematosus following myasthenia gravis and thymoma (1987) J Am Acad Dermatol, 16, pp. 472-480; \n\nCrotty, C., Pittelkow, M., Muller, S.A., Eosinophilic spongiosis: a clinicopathologic review of seventy-one cases (1983) J Am Acad Dermatol, 8, pp. 337-343; \n\nHymes, S.R., Jordon, R.E., Pemphigus foliaceus (1992) Use of antimalarial agents as adjuvant therapy. Arch Dermatol, 128, pp. 1462-1464; \n\nSami, N., Qureshi, A., Ahmed, A.R., Steroid sparing effect of intravenous immunoglobulin therapy in patients with pemphigus foliaceus (2002) Eur J Dermatol, 12, pp. 174-178; \n\nAhmed, A.R., Sami, N., Intravenous immunoglobulin therapy for patients with pemphigus foliaceus unresponsive to conventional therapy (2002) J Am Acad Dermatol, 46, pp. 42-49; \n\nBasset, N., Guillot, B., Michel, B., Dapsone as initial treatment in superficial pemphigus (1987) Report of nine cases. Arch Dermatol, 123, pp. 783-785; \n\nMaciejowska, E., Jablonska, S., Chorzelski, T., Is pemphigus herpetiformis an entity? (1987) Int J Dermatol, 26, pp. 571-577; \n\nBauer, R., Stadler, R., Immel, C., [Acantholysis and eosinophilic spongiosis: pemphigus herpetiformis (1983) Successful retinoid therapy]. Hautarzt, 34, pp. 13-17; \n\nKatz, K.H., Marks Jr, J.G., Helm, K.F., Pemphigus foliaceus successfully treated with mycophenolate mofetil as a steroid-sparing agent (2000) J Am Acad Dermatol, 42, pp. 514-515; \n\nChams-Davatchi, C., Nonahal Azar, R., Daneshpazooh, M., [Open trial of mycophenolate mofetil in the treatment of resistant pemphigus vulgaris] (2002) Ann Dermatol Venereol, 129, pp. 23-25; \n\nChaffins, M.L., Collison, D., Fivenson, D.P., Treatment of pemphigus and linear IgA dermatosis with nicotinamide and tetracycline: a review of 13 cases (1993) J Am Acad Dermatol, 28, pp. 998-1000; \n\nAlpsoy, E., Yilmaz, E., Basaran, E., Is the combination of tetracycline and nicotinamide therapy alone effective in pemphigus? (1995) Arch Dermatol, 131, pp. 1339-1340; \n\nZaraa, I., Mokni, M., Hsairi, M., Pemphigus vulgaris and pemphigus foliaceus: similar prognosis? (2007) Int J Dermatol, 46, pp. 923-926; \n\nIshii, K., Amagai, M., Ohata, Y., Development of pemphigus vulgaris in a patient with pemphigus foliaceus: antidesmoglein antibody profile shift confirmed by enzyme-linked immunosorbent assay (2000) J Am Acad Dermatol, 42, pp. 859-861; \n\nTsuji, Y., Kawashima, T., Yokota, K., Clinical and serological transition from pemphigus vulgaris to pemphigus foliaceus demonstrated by desmoglein ELISA system (2002) Arch Dermatol, 138, pp. 95-96; \n\nHarman, K.E., Gratian, M.J., Shirlaw, P.J., The transition of pemphigus vulgaris into pemphigus foliaceus: a reflection of changing desmoglein 1 and 3 autoantibody levels in pemphigus vulgaris (2002) Br J Dermatol, 146, pp. 684-687; \n\nSami, N., Bhol, K.C., Ahmed, A.R., Diagnostic features of pemphigus vulgaris in patients with pemphigus foliaceus: detection of both autoantibodies, long-term follow-up and treatment responses (2001) Clin Exp Immunol, 125, pp. 492-498; \n\nKomai, A., Amagai, M., Ishii, K., The clinical transition between pemphigus foliaceus and pemphigus vulgaris correlates well with the changes in autoantibody profile assessed by an enzyme-linked immunosorbent assay (2001) Br J Dermatol, 144, pp. 1177-1182; \n\nMuller, E., Kernland, K., Caldelari, R., Unusual pemphigus phenotype in the presence of a Dsg1 and Dsg3 autoantibody profile (2002) J Invest Dermatol, 118, pp. 551-555; \n\nHans-Filho, G., Aoki, V., Rivitti, E., Endemic pemphigus foliaceus (fogo selvagem)-1998 (1999) The Cooperative Group on Fogo Selvagem Research. Clin Dermatol, 17, pp. 225-235; \n\nMorini, J.P., Jomaa, B., Gorgi, Y., Pemphigus foliaceus in young women (1993) An endemic focus in the Sousse area of Tunisia. Arch Dermatol, 129, pp. 69-73; \n\nBastuji-Garin, S., Souissi, R., Blum, L., Comparative epidemiology of pemphigus in Tunisia and France: unusual incidence of pemphigus foliaceus in young Tunisian women (1995) J Invest Dermatol, 104, pp. 302-305; \n\nJoly, P., Mokhtar, I., Gilbert, D., Immunoblot and immunoelectronmicroscopic analysis of endemic Tunisian pemphigus (1999) Br J Dermatol, 140, pp. 44-49; \n\nCulton, D.A., Qian, Y., Li, N., Advances in pemphigus and its endemic pemphigus foliaceus (Fogo Selvagem) phenotype: a paradigm of human autoimmunity (2008) J Autoimmun, 31, pp. 311-324; \n\nMoraes, M.E., Fernandez-Vina, M., Lazaro, A., An epitope in the third hypervariable region of the DRB1 gene is involved in the susceptibility to endemic pemphigus foliaceus (fogo selvagem) in three different Brazilian populations (1997) Tissue Antigens, 49, pp. 35-40; \n\nFutamura, S., Martins, C., Rivitti, E.A., Ultrastructural studies of acantholysis induced in vivo by passive transfer of IgG from endemic pemphigus foliaceus (Fogo Selvagem) (1989) J Invest Dermatol, 93, pp. 480-485; \n\nAkiyama, M., Hashimoto, T., Sugiura, M., Ultrastructural localization of Brazilian pemphigus foliaceus (fogo selvagem) antigens in cultured human squamous cell carcinoma cells (1993) Br J Dermatol, 128, pp. 378-383; \n\nCunha, P.R., Bystryn, J.C., Medeiros, E.P., Sensitivity of indirect immunofluorescence and ELISA in detecting intercellular antibodies in endemic pemphigus foliaceus (Fogo Selvagem) (2006) Int J Dermatol, 45, pp. 914-918; \n\nDmochowski, M., Hashimoto, T., Garrod, D.R., Desmocollins I and II are recognized by certain sera from patients with various types of pemphigus, particularly Brazilian pemphigus foliaceus (1993) J Invest Dermatol, 100, pp. 380-384; \n\nDmochowski, M., Hashimoto, T., Chidgey, M.A., Demonstration of antibodies to bovine desmocollin isoforms in certain pemphigus sera (1995) Br J Dermatol, 133, pp. 519-525; \n\nRivitti, E.A., Sanches, J.A., Miyauchi, L.M., Pemphigus foliaceus autoantibodies bind both epidermis and squamous mucosal epithelium, but tissue injury is detected only in the epidermis (1994) The Cooperative Group on Fogo Selvagem Research. J Am Acad Dermatol, 31, pp. 954-958; \n\nGuedes, A.C., Rotta, O., Leite, H.V., Ultrastructural aspects of mucosas in endemic pemphigus foliaceus (2002) Arch Dermatol, 138, pp. 949-954; \n\nWarren, S.J., Lin, M.S., Giudice, G.J., The prevalence of antibodies against desmoglein 1 in endemic pemphigus foliaceus in Brazil (2000) Cooperative Group on Fogo Selvagem Research. N Engl J Med, 343, pp. 23-30; \n\nLi, N., Aoki, V., Hans-Filho, G., The role of intramolecular epitope spreading in the pathogenesis of endemic pemphigus foliaceus (fogo selvagem) (2003) J Exp Med, 197, pp. 1501-1510; \n\nDiaz, L.A., Prisayanh, P.S., Dasher, D.A., The IgM anti-desmoglein 1 response distinguishes Brazilian pemphigus foliaceus (fogo selvagem) from other forms of pemphigus (2008) J Invest Dermatol, 128, pp. 667-675; \n\nHilario-Vargas, J., Dasher, D.A., Li, N., Prevalence of anti-desmoglein-3 antibodies in endemic regions of Fogo selvagem in Brazil (2006) J Invest Dermatol, 126, pp. 2044-2048; \n\nDiaz, L.A., Arteaga, L.A., Hilario-Vargas, J., Anti-desmoglein-1 antibodies in onchocerciasis, leishmaniasis and Chagas disease suggest a possible etiological link to Fogo selvagem (2004) J Invest Dermatol, 123, pp. 1045-1051; \n\nWarren, S.J., Arteaga, L.A., Rivitti, E.A., The role of subclass switching in the pathogenesis of endemic pemphigus foliaceus (2003) J Invest Dermatol, 120, pp. 104-108; \n\nMoraes, J.R., Moraes, M.E., Fernandez-Vina, M., HLA antigens and risk for development of pemphigus foliaceus (fogo selvagem) in endemic areas of Brazil (1991) Immunogenetics, 33, pp. 388-391; \n\nDiaz, L.A., Sampaio, S.A., Rivitti, E.A., Endemic pemphigus foliaceus (fogo selvagem) (1989) I. Clinical features and immunopathology. J Am Acad Dermatol, 20, pp. 657-669; \n\nSampaio, S.A., Rivitti, E.A., Aoki, V., Brazilian pemphigus foliaceus, endemic pemphigus foliaceus, or fogo selvagem (wild fire) (1994) Dermatol Clin, 12, pp. 765-776; \n\nRocha-Alvarez, R., Friedman, H., Campbell, I.T., Pregnant women with endemic pemphigus foliaceus (Fogo Selvagem) give birth to disease-free babies (1992) J Invest Dermatol, 99, pp. 78-82; \n\nAvalos-Diaz, E., Olague-Marchan, M., Lopez-Swiderski, A., Transplacental passage of maternal pemphigus foliaceus autoantibodies induces neonatal pemphigus (2000) J Am Acad Dermatol, 43, pp. 1130-1134; \n\nWu, H., Wang, Z.H., Yan, A., Protection against pemphigus foliaceus by desmoglein 3 in neonates (2000) N Engl J Med, 343, pp. 31-35; \n\nKuechle, M.K., Hutton, K.P., Muller, S.A., Angiotensin-converting enzyme inhibitorinduced pemphigus: three case reports and literature review (1994) Mayo Clin Proc, 69, pp. 1166-1171; \n\nVignes, S., Paul, C., Flageul, B., Ramipril-induced superficial pemphigus (1996) Br J Dermatol, 135, pp. 657-658; \n\nOng, C.S., Cook, N., Lee, S., Drug-related pemphigus and angiotensin converting enzyme inhibitors (2000) Australas J Dermatol, 41, pp. 242-246; \n\nBae, Y.I., Yun, S.J., Lee, S.C., Pemphigus foliaceus induced by an angiotensin II receptor blocker (2008) Clin Exp Dermatol, 33, pp. 721-723; \n\nBrenner, S., Bialy-Golan, A., Ruocco, V., Drug-induced pemphigus (1998) Clin Dermatol, 16, pp. 393-397; \n\nGhaffarpour, G., Jalali, M.H., Yaghmaii, B., Chloroquine/hydroxychloroquineinduced pemphigus (2006) Int J Dermatol, 45, pp. 1261-1263; \n\nFleischmann, M., Celerier, P., Bernard, P., Long-term interferon-alpha therapy induces autoantibodies against epidermis (1996) Dermatology, 192, pp. 50-55; \n\nCetkovska, P., Pizinger, K., Childhood pemphigus associated with montelukast administration (2003) Clin Exp Dermatol, 28, pp. 328-329; \n\nLow, G.J., Keeling, J.H., Ionizing radiation-induced pemphigus (1990) Case presentations and literature review. Arch Dermatol, 126, pp. 1319-1323; \n\nAmbay, A., Stratman, E., Ionizing radiation-induced pemphigus foliaceus (2006) J Am Acad Dermatol, 54, pp. 251-252; \n\nRobbins, A.C., Lazarova, Z., Janson, M.M., Pemphigus vulgaris presenting in a radiation portal (2007) J Am Acad Dermatol, 56. , S82-5; \n\nHogan, P., Pemphigus vulgaris following a cutaneous thermal burn (1992) Int J Dermatol, 31, pp. 46-49; \n\nTan, S.R., McDermott, M.R., Castillo, C.J., Pemphigus vulgaris induced by electrical injury (2006) Cutis, 77, pp. 161-165; \n\nRuocco, V., Brenner, S., Ruocco, E., Pemphigus and diet: does a link exist? (2001) Int J Dermatol, 40, pp. 161-163; \n\nMemar, O.M., Rady, P.L., Goldblum, R.M., Human herpesvirus 8 DNA sequences in blistering skin from patients with pemphigus (1997) Arch Dermatol, 133, pp. 1247-1251; \n\nTufano, M., Baroni, A., Buommino, E., Detection of virus DNA in peripheral blood mononuclear cells and skin lesions of patients with pemphigus by polymerase chain reaction (1999) Br J Dermatol, 141, pp. 1033-1039; \n\nDupin, N., Marcelin, A.G., Gorin, I., Prevalence of human herpesvirus 8 infection measured by antibodies to a latent nuclear antigen in patients with various dermatologic diseases (1998) Arch Dermatol, 134, pp. 700-702; \n\nMatzner, Y., Erlich, H.A., Brautbar, C., Identical HLA class II alleles predispose to drug-triggered and idiopathic pemphigus vulgaris (1995) Acta Derm Venereol, 75, pp. 12-14; \n\nKorman, N.J., Eyre, R.W., Zone, J., Drug-induced pemphigus: autoantibodies directed against the pemphigus antigen complexes are present in penicillamine and captopril-induced pemphigus (1991) J Invest Dermatol, 96, pp. 273-276; \n\nBrenner, S., Bialy-Golan, A., Anhalt, G.J., Recognition of pemphigus antigens in drug-induced pemphigus vulgaris and pemphigus foliaceus (1997) J Am Acad Dermatol, 36, pp. 919-923; \n\nNagao, K., Tanikawa, A., Yamamoto, N., Decline of anti-desmoglein 1 IgG ELISA scores by withdrawal of D-penicillamine in drug-induced pemphigus foliaceus (2005) Clin Exp Dermatol, 30, pp. 43-45; \n\nRobinson, N.D., Hashimoto, T., Amagai, M., The new pemphigus variants (1999) J Am Acad Dermatol, 40, pp. 649-671. , quiz 72-3; \n\nOngenae, K.C., Temmerman, L.J., Vermander, F., Intercellular IgA dermatosis (1999) Eur J Dermatol, 9, pp. 85-94; \n\nTagami, H., Iwatsuki, K., Iwase, Y., Subcorneal pustular dermatosis with vesiculo-bullous eruption (1983) Demonstration of subcorneal IgA deposits and a leukocyte chemotactic factor. Br J Dermatol, 109, pp. 581-587; \n\nHuff, J.C., Golitz, L.E., Kunke, K.S., Intraepidermal neutrophilic IgA dermatosis (1985) N Engl J Med, 313, pp. 1643-1645; \n\nHeng, A., Nwaneshiudu, A., Hashimoto, T., Intraepidermal neutrophilic IgA/ IgG antidesmocollin 1 pemphigus (2006) Br J Dermatol, 154, pp. 1018-1020; \n\nHashimoto, T., Ebihara, T., Nishikawa, T., Studies of autoantigens recognized by IgA anti-keratinocyte cell surface antibodies (1996) J Dermatol Sci, 12, pp. 10-17; \n\nYasuda, H., Kobayashi, H., Hashimoto, T., Subcorneal pustular dermatosis type of IgA pemphigus: demonstration of autoantibodies to desmocollin-1 and clinical review (2000) Br J Dermatol, 143, pp. 144-148; \n\nHashimoto, T., Komai, A., Futei, Y., Detection of IgA autoantibodies to desmogleins by an enzyme-linked immunosorbent assay: the presence of new minor subtypes of IgA pemphigus (2001) Arch Dermatol, 137, pp. 735-738; \n\nIshii, N., Ishida-Yamamoto, A., Hashimoto, T., Immunolocalization of target autoantigens in IgA pemphigus (2004) Clin Exp Dermatol, 29, pp. 62-66; \n\nKopp, T., Sitaru, C., Pieczkowski, F., IgA pemphigus-occurrence of antidesmocollin 1 and anti-desmoglein 1 antibody reactivity in an individual patient (2006) J Dtsch Dermatol Ges, 4, pp. 1045-1050; \n\nProst, C., Intrator, L., Wechsler, J., IgA autoantibodies bind to pemphigus vulgaris antigen in a case of intraepidermal neutrophilic IgA dermatosis (1991) J Am Acad Dermatol, 25, pp. 846-848; \n\nGengoux, P., Tennstedt, D., Lachapelle, J.M., Intraepidermal neutrophilic IgA dermatosis: pemphigus-like IgA deposits (1992) Dermatology, 185, pp. 311-313; \n\nWang, J., Kwon, J., Ding, X., Nonsecretory IgA1 autoantibodies targeting desmosomal component desmoglein 3 in intraepidermal neutrophilic IgA dermatosis (1997) Am J Pathol, 150, pp. 1901-1907; \n\nNiimi, Y., Kawana, S., Kusunoki, T., IgA pemphigus: a case report and its characteristic clinical features compared with subcorneal pustular dermatosis (2000) J Am Acad Dermatol, 43, pp. 546-549; \n\nWallach, D., Intra-epidermal immunoglobulin A pustulosis (1990) Dermatologica, 181, pp. 261-263; \n\nChorzelski, T.P., Beutner, E.H., Kowalewski, C., IgA pemphigus foliaceus with a clinical presentation of pemphigus herpetiformis (1991) J Am Acad Dermatol, 24, pp. 839-844; \n\nHarman, K.E., Holmes, G., Bhogal, B.S., Intercellular IgA dermatosis (IgA pemphigus)-two cases illustrating the clinical heterogeneity of this disorder (1999) Clin Exp Dermatol, 24, pp. 464-466; \n\nWeston, W.L., Friednash, M., Hashimoto, T., A novel childhood pemphigus vegetans variant of intraepidermal neutrophilic IgA dermatosis (1998) J Am Acad Dermatol, 38, pp. 635-638; \n\nWallach, D., Intraepidermal IgA pustulosis (1992) J Am Acad Dermatol, 27, pp. 993-1000; \n\nTakata, M., Inaoki, M., Shodo, M., Subcorneal pustular dermatosis associated with IgA myeloma and intraepidermal IgA deposits (1994) Dermatology, 189 (SUPPL. 1), pp. 111-114; \n\nMyers, S.A., Rico, M.J., Intraepidermal neutrophilic IgA dermatosis in an HIVinfected patient (1994) J Am Acad Dermatol, 31, pp. 501-504; \n\nMuldrow, M., Intraepidermal neutrophilic Iga dermatosis in a patient with advanced human immunodeficiency virus infection (1997) Arch Dermatol, 133, pp. 667-668; \n\nBarnadas, M., Nadal, C., Verger, G., Intraepidermal IgA pustulosis with monoclonal IgA gammopathy in an HIV-infected patient (1997) Dermatology, 194, pp. 308-309; \n\nBorradori, L., Saada, V., Rybojad, M., Intraepidermal neutrophilic IgA pustulosis and Crohn's disease (1992) Br J Dermatol, 126, pp. 383-386; \n\nVarigos, G.A., Subcorneal pustulosis with IgA abnormalities in serum and small bowel mucosa: case report (1979) Aust J Dermatol, 20, pp. 75-77; \n\nKishimoto, K., Iwatsuki, K., Akiba, H., Subcorneal pustular dermatosis-type IgA pemphigus induced by thiol drugs (2001) Eur J Dermatol, 11, pp. 41-44; \n\nHashimoto, T., Inamoto, N., Nakamura, K., Intercellular IgA dermatosis with clinical features of subcorneal pustular dermatosis (1987) Arch Dermatol, 123, pp. 1062-1065; \n\nTodd, D.J., Bingham, E.A., Walsh, M., Subcorneal pustular dermatosis and IgA paraproteinaemia: response to both etretinate and PUVA (1991) Br J Dermatol, 125, pp. 387-389; \n\nGruss, C., Zillikens, D., Hashimoto, T., Rapid response of IgA pemphigus of subcorneal pustular dermatosis type to treatment with isotretinoin (2000) J Am Acad Dermatol, 43, pp. 923-926; \n\nSibley Hash, K., Rencic, A., Hernandez, M.I., Aggressive immunosuppressive therapy for a refractory case of IgA pemphigus (2002) Arch Dermatol, 138, pp. 744-746; \n\nHodak, E., Lapidoth, M., David, M., Effect of colchicine in the subcorneal pustular dermatosis type of IgA pemphigus (1999) J Am Acad Dermatol, 40, pp. 91-94; \n\nSneddon, I., Wilkinson, D., Subcorneal pustular dermatosis (1956) Br J Dermatol, 68, pp. 385-394; \n\nReed, J., Wilkinson, J., Subcorneal pustular dermatosis (2000) Clin Dermatol, 18, pp. 301-313; \n\nVenning, V.A., Ryan, T.J., Subcorneal pustular dermatosis followed by pyoderma gangrenosum (1986) Br J Dermatol, 115, pp. 117-118; \n\nRoger, H., Thevenet, J.P., Souteyrand, P., Subcorneal pustular dermatosis associated with rheumatoid arthritis and raised IgA: simultaneous remission of skin and joint involvements with dapsone treatment (1990) Ann Rheum Dis, 49, pp. 190-191; \n\nDelaporte, E., Colombel, J.F., Nguyen-Mailfer, C., Subcorneal pustular dermatosis in a patient with Crohn's disease (1992) Acta Derm Venereol, 72, pp. 301-302; \n\nSzabo, E., Hamm, H., Subkorneale pustulose Sneddon-Wilkinson mit IgG lambdaparaproteinamie (1992) HG Z Hautkrank, 67, pp. 792-795; \n\nCartier, H., Plantin, P., Leroy, J.P., [Pyoderma gangrenosum, subcorneal IgA pustulosis and recurrent neutrophilic pleural and pulmonary diseases in a patient with IgA gammopathy] (1995) Ann Dermatol Venereol, 122, pp. 97-101; \n\nLautenschlager, S., Itin, P.H., Hirsbrunner, P., Subcorneal pustular dermatosis at the injection site of recombinant human granulocyte-macrophage colonystimulating factor in a patient with IgA myeloma (1994) J Am Acad Dermatol, 30, pp. 787-789; \n\nGrob, J.J., Mege, J.L., Capo, C., Role of tumor necrosis factor-alpha in Sneddon-Wilkinson subcorneal pustular dermatosis (1991) A model of neutrophil priming in vivo. J Am Acad Dermatol, 25, pp. 944-947; \n\nIwatsuki, K., Imaizumi, S., Takagi, M., Intercellular IgA deposition in patients with clinical features of subcorneal pustular dermatosis (1988) Br J Dermatol, 119, pp. 545-547; \n\nLutz, M.E., Daoud, M.S., McEvoy, M.T., Subcorneal pustular dermatosis: a clinical study of ten patients (1998) Cutis, 61, pp. 203-208; \n\nIshii, N., Ishida-Yamamoto, A., Hashimoto, T., Immunolocalization of target autoantigens in IgA pemphigus (2004) Clin Exp Dermatol, 29, pp. 62-66; \n\nKopp, T., Sitaru, C., Pieczkowski, F., IgA pemphigus-occurrence of antidesmocollin 1 and anti-desmoglein 1 antibody", "hasCitationDuplums" : false, "userChangeableUntil" : "2016-04-11T12:30:53.000+0000", "publishDate" : "2016-01-12T13:30:53.000+0000", "directInstitutesForSort" : "", "ownerAuthorCount" : 13, "ownerInstituteCount" : 38, "directInstituteCount" : 0, "authorCount" : 2, "contributorCount" : 0, "book" : { "otype" : "Book", "mtid" : 30127741, "link" : "/api/publication/30127741", "label" : "Tom Burns. Rook's Textbook of Dermatology: Eighth Edition. (2010) ISBN:9781405161695", "core" : false, "citation" : false, "publicationPending" : false, "type" : { "otype" : "PublicationType", "mtid" : 23, "link" : "/api/publicationtype/23", "label" : "Könyv", "code" : 23, "otypeName" : "Book", "listPosition" : 3, "published" : true, "oldId" : 23, "snippet" : true }, "subType" : { "otype" : "SubType", "mtid" : 10000201, "link" : "/api/subtype/10000201", "label" : "Szakkönyv (Könyv)", "name" : "Szakkönyv", "nameEng" : "Monograph", "docType" : { "otype" : "PublicationType", "mtid" : 23, "link" : "/api/publicationtype/23", "label" : "Könyv", "code" : 23, "otypeName" : "Book", "listPosition" : 3, "published" : true, "oldId" : 23, "snippet" : true }, "listPosition" : 337, "published" : true, "oldId" : 10000201, "snippet" : true }, "category" : { "otype" : "Category", "mtid" : 1, "link" : "/api/category/1", "label" : "Tudományos", "published" : true, "oldId" : 1, "snippet" : true }, "languages" : [ { "otype" : "Language", "mtid" : 10002, "link" : "/api/language/10002", "label" : "Angol", "name" : "Angol", "nameEng" : "English", "published" : true, "oldId" : 2, "snippet" : true } ], "title" : "Rook's Textbook of Dermatology: Eighth Edition", "identifiers" : [ { "otype" : "PublicationIdentifier", "mtid" : 6979038, "link" : "/api/publicationidentifier/6979038", "label" : "ISBN: 9781405161695", "source" : { "otype" : "PlainSource", "mtid" : 122, "link" : "/api/publicationsource/122", "label" : "ISBN", "type" : { "otype" : "PublicationSourceType", "mtid" : 10002, "link" : "/api/publicationsourcetype/10002", "label" : "Egyéb", "mayHaveOa" : false, "published" : true, "snippet" : true }, "name" : "ISBN", "nameEng" : "ISBN", "linkPattern" : "https://www.worldcat.org/search?q=isbn%3A@@@", "publiclyVisible" : true, "published" : true, "oldId" : 122, "snippet" : true }, "idValue" : "9781405161695", "realUrl" : "https://www.worldcat.org/search?q=isbn%3A9781405161695", "published" : false, "snippet" : true } ], "publishedAt" : [ { "otype" : "City", "mtid" : 10495, "link" : "/api/city/10495", "label" : "Oxford, Egyesült Királyság / Anglia", "partOf" : { "otype" : "Country", "mtid" : 10175, "link" : "/api/country/10175", "label" : "Egyesült Királyság / Anglia", "published" : true, "oldId" : 2151760, "snippet" : true }, "published" : true, "oldId" : 1027404, "snippet" : true } ], "publishedYear" : 2010, "foreignEdition" : true, "foreignLanguage" : true, "fullPublication" : true, "conferencePublication" : false, "nationalOrigin" : false, "published" : true, "snippet" : true }, "hasQualityFactor" : false, "link" : "/api/publication/25269519", "label" : "Wojnarowska F et al. Immunobullous Diseases. (2010) Megjelent: Rook's Textbook of Dermatology: Eighth Edition pp. 1855-1916", "template" : "